- December 12, 2022
COVID Restrictions May Have Contributed to Increase in RSV Infections. But Relief Could Be Coming Soon.
- January 31, 2022
Two New Haven Locations Use Yale’s SalivaDirect COVID-19 Test
- January 27, 2022Source: The New Haven Register
New partnership between CT, Yale to expand saliva-based COVID testing at 2 New Haven locations
- November 02, 2021Source: YaleNews
FDA Authorizes Sample Pooling for Yale-developed SalivaDirect COVID Test
- August 26, 2020
Sex Differences in COVID-19 Immune Responses Affect Patient Outcomes
- August 15, 2020Source: YaleNews
Quick and Affordable Saliva-based COVID-19 Test Developed by Yale Scientists Receives FDA Emergency Use Authorization
Welcome
Our research focuses on the mechanisms driving the observed epidemiological patterns of respiratory infections, particularly pneumococcal disease and RSV. Pneumococcus causes a large burden of disease worldwide, particularly among young children and the elderly.
Major research questions in the lab are related to long-term bacterial evolution, impacts of immunization on carriage and disease in different populations, and seasonal determinants of bacterial disease incidence (including viral co-infections and carriage). These projects utilize both quantitative tools and experimental laboratory studies.
You can learn more about our research and recent publications here.